Cooper Companies | COO - Aktuelle Verpflichtungen

Aktienkurs
64.42
Täglich Wechseln
-0.53 -0.82%
Monatlich
-9.84%
Jährlich
-20.36%
Q2 Prognose
63.04




Aktuelle Verpflichtungen Veränderung Datum
Abbott USD 16.5B 1.91B 2025-12
Align Technology USD 1.92B 46.45M 2025-12
AtriCure USD 81.52M 3.68M 2025-12
Avanos Medical USD 165.2M 17.3M 2025-12
Bausch Health Companies USD 4.18B 613M 2025-12
Baxter International USD 2.97B 805M 2025-12
Bayer EUR 32.58B 3.63B 2025-12
Becton, Dickinson and Co. USD 8.76B 448M 2025-12
Boston Scientific USD 5.44B 111M 2025-12
Cooper Companies USD 1.6B 482.9M 2025-12
Dentsply International USD 1.34B 62M 2025-12
Dexcom USD 2.14B 1.19B 2025-12
Edwards Lifesciences USD 1.81B 225.7M 2025-12
Globus Medical USD 498.5M 32.54M 2025-12
Haemonetics USD 539.87M 8.45M 2025-12
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 680.1M 32.4M 2025-12
Integra LifeSciences USD 455.98M 91.93M 2025-12
Intuitive Surgical USD 2.51B 3.2M 2026-03
J&J USD 57.72B 3.59B 2026-03
Medtronic USD 9.5B 440M 2025-12
Merit Medical Systems USD 239.76M 9.29M 2025-12
Novartis USD 27.28B 4.72B 2025-12
ResMed USD 1.25B 7.39M 2025-12
STAAR Surgical USD 68.5M 6.87M 2025-12
Steris USD 922.3M 33.4M 2025-12
Stryker USD 7.79B 380M 2025-12
Tandem Diabetes Care USD 242.72M 9.82M 2025-12
Teleflex USD 762.03M 11.01M 2025-12
Utah Medical Products USD 2.6M 413K 2025-12
Zimmer Biomet Holdings USD 2.58B 180.8M 2025-12